Profound impairment of adaptive immune responses by alkylating chemotherapy
about
How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future DirectionsModulation of APC Function and Anti-Tumor Immunity by Anti-Cancer DrugsImmunotherapy advances for glioblastomaSeizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic reviewExpression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenograftsCombination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses.Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacySingle-fraction radiation therapy in patients with metastatic Merkel cell carcinomaRepeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model.CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma modelThe multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinomaCellular immunotherapy for malignant gliomas.Immunological effects of chemotherapy and radiotherapy against brain tumors.STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.A Review of Immune Therapy in Cancer and a Question: Can Thermal Therapy Increase Tumor Response?Antigen-specific culture of memory-like CD8 T cells for adoptive immunotherapy.Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination.Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival.Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM.Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide.Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide.
P2860
Q26771113-1DB40411-3068-457D-86EB-661AEC40BB27Q26781522-B8874DDE-67B7-461F-B830-1C80283D6A28Q26866513-EAEF9A7D-E97E-4ABF-8539-014D3BC020F6Q27027730-300DD2D5-22E3-4057-A8E6-88B4FA1AC72EQ33606096-285B7F46-F776-4072-B25A-F9D4B37A7D4FQ34457611-451CC931-3992-4C6B-9A7A-ECE0A41B6E00Q35163556-F94DBF5B-4A45-48EE-8D1B-46E7A0798ADFQ35546240-C3A9D8B1-063D-4B47-A5BA-560B2EDCE917Q35561280-92D903F1-8DA5-48A2-81A3-9FC287A16A11Q35594838-D22E6DFF-706F-4FBA-983D-71D5774D7771Q35657822-5FC382A7-6560-4691-B2C2-C68962C2746BQ36023855-BBD82EF2-6C12-42C1-B30E-224CED947B80Q36137504-441FFC82-B737-428A-A5E8-AD991826B098Q36600960-480A156A-958E-4A9F-BA87-4B65A842771CQ37012579-DBFDF53F-40BF-4BD4-BF28-067D8DFE32F6Q37321033-2BD90773-159F-4A4D-A05D-4CB6971D91EBQ38902169-0E84558D-EEF8-4D33-A981-5543070753B9Q38947116-08483F8F-6326-441A-8771-73AFC4EEEC45Q38949322-8C9963A2-6B09-4744-9133-E8F12A3FF90DQ41928232-A303AF54-9385-4167-87CB-35AE19030EFDQ42124330-3EC5195C-6886-41B9-B3AF-C47EDEB5505CQ42177990-84A0CDF1-EE3F-41D6-80DA-8AE1DCB586BDQ42639856-F205E772-47C5-4BF7-AC43-14E340E1AEB8Q47161862-777868B3-C318-47EB-A3D0-B0596C1284F8Q48641340-A32A1B41-776A-47E1-ACF1-F0BC299AFF14Q52597547-ACC13BA1-50CB-443E-9807-EA093FF4039D
P2860
Profound impairment of adaptive immune responses by alkylating chemotherapy
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Profound impairment of adaptive immune responses by alkylating chemotherapy
@en
type
label
Profound impairment of adaptive immune responses by alkylating chemotherapy
@en
prefLabel
Profound impairment of adaptive immune responses by alkylating chemotherapy
@en
P2093
P2860
P356
P1476
Profound impairment of adaptive immune responses by alkylating chemotherapy
@en
P2093
Adam J Litterman
Andres M Salazar
Arkadiusz Z Dudek
David M Zellmer
John R Ohlfest
Karen L Grinnen
Matthew A Hunt
P2860
P304
P356
10.4049/JIMMUNOL.1203539
P407
P577
2013-05-17T00:00:00Z